Durable Clinical Benefits with Exagamglogene Autotemcel for over 5 Years of Follow-up in Transfusion-Dependent Thalassemia and Sickle Cell Disease with Recurrent Vaso-Occlusive Crises

Transplantation and Cellular Therapy 2026

View at publisher
Authors: Monica Bhatia, Haydar Frangoul, Franco Locatelli, Peter Lang, Akshay Sharma, Roland Meisel, Selim Corbacioglu, Josu de la Fuente, Markus Y. Mapara, Lyndsay Molinari, Robert Liem, Laurence Dedeken
+13 more Amanda Li, Ami J. Shah, Mattia Algeri, Ben Carpenter, Janet L. Kwiatkowski, Joachim Rupprecht, Hayley Lynne Merkeley, Kevin H.M. Kuo, Kevin Boerner, Tina Liu, Sakellarios Zairis, William Hobbs, Stephan A. Grupp
DOI: 10.1016/j.jtct.2025.12.016
Cited by: 1

Fields of Study & Subjects

Hemoglobinopathies and Related Disorders Blood groups and transfusion Myeloproliferative Neoplasms: Diagnosis and Treatment

Publication details

Journal / source
Transplantation and Cellular Therapy
Publisher
Elsevier BV
Volume
32
Issue
2
Pages
S2–S3
Publication date
1 February 2026
Language
EN